Episode 310: Dosing and Duration of Drugs From a Cost Perspective

Daniel Goldstein returns to the podcast to discuss dosing issues and dosing changes in drugs such as nivolumab and pembrolizumab, as well as other immune checkpoint inhibitors.

Dr. Goldstein is a Senior Physician at the Davidoff Cancer Center of Rabin Medical Center, and serves as Senior Lecturer at Tel Aviv University.